Masaru Matsuda

See Remarks

Masaru Matsuda (See Remarks) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in Arcutis Biotherapeutics, Inc. (ARQT). The largest single filing was $1.0M of ARQT (40,638 sh across 4 lots, as filed), executed Feb 2.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 5 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$1.8M

shares × price, as filed

Last traded

Sep 8

Filed Sep 10

Median ADV $51.3M across their filed names

Open performance→

Volume by month

Buys $0 Sells $2.5M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 5 filings

Sector per market data · by filing · past 12 months

Most traded names

ARQT

Arcutis Biotherapeutics, Inc. ARQT · 0 buys · 7 sells 7 filings

Recent filings

ARQTSALE Arcutis Biotherapeutics, Inc. View filing → $250K
9,989 sh × $25.03
Exec Sep 8
Filed Sep 10 · 7:24 PM ET ARQTSALE Arcutis Biotherapeutics, Inc. View filing → $172K
7,372 sh × $23.27
Exec May 4
Filed May 6 · 5:30 PM ET ARQTSALE Arcutis Biotherapeutics, Inc. View filing → $165K
6,553 sh × $25.16
Exec Mar 2
Filed Mar 3 · 5:30 PM ET ARQTSALE Arcutis Biotherapeutics, Inc. View filing → $1.0M
40,638 sh across 4 lots
Exec Feb 2
Filed Feb 4 · 5:30 PM ET ARQTSALE Arcutis Biotherapeutics, Inc. View filing → $177K
7,165 sh × $24.71
Exec Nov 3 2025
Filed Nov 5 2025 · 5:30 PM ET ARQTSALE Arcutis Biotherapeutics, Inc. View filing → $584K
36,130 sh × $16.16
Exec Sep 4 2025
Filed Sep 8 2025 · 5:30 PM ET ARQTSALE Arcutis Biotherapeutics, Inc. View filing → $106K
8,338 sh × $12.70
Exec Feb 3 2025
Filed Feb 4 2025 · 5:30 PM ET